Silene holds a BSc (Hons) in Psychology from the University of Stirling and an MSc in Mental health in Children and Young People from the University of Edinburgh. She has experience in conducting qualitative research through a placement at the University of Stirling’s Careers and Employability Service and quantitative research experience, using both primary and secondary data, through her degree research projects. Silene also has experience in supporting individuals with mental health difficulties through voluntary roles during her time at university, such as Nightline, and healthcare experience through her role as a care and support worker for individuals with learning difficulties and complex needs. Silene is big on advocating for inclusivity and supporting vulnerable populations and is therefore enthusiastic about filling research gaps by expanding on current research to improve the understanding of myeloma patient experience and quality of life. Silene speaks English, French, German and Dutch and is currently based in Edinburgh.
EMA committee recommends teclistamab plus daratumumab for relapsed or refractory multiple myeloma
On 25 June 2026, the Committee for Medicinal Products for Human Use (CHMP) recommended extending the approved use of teclistamab (Tecvayli®) to include its use in combination with daratumumab for…